CG Oncology
Biotech · Public
Cretostimogene oncolytic adenovirus (intravesical immunotherapy for bladder cancer)
cgoncology.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 21
- 5 granted · 16 pending
- Sector median: 2
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2878 | SPECTRAL THERAPEUTICS, INC. | — | — |
| 2879 | CYPRESS BIOPHARMA, INC. | — | — |
| 2880 | Sophia Bioscience Inc | — | — |
| 2881 | CG Oncology | — | — |
| 2882 | LABORECOM THERAPEUTICS INC. | — | — |
| 2883 | BIOCOGNON LLC | — | — |
| 2884 | MYOLOGICA, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Methods Of Treating Bladder Cancerapplication
- Methods Of Treating Solid Or Lymphatic Tumors By Combination Therapyapplication
- Methods Of Treating Bladder Cancergranted
- Methods Of Treating Solid Or Lymphatic Tumors By Combination Therapygranted
- Methods Of Treating Bladder Cancergranted
- Methods Of Treating Bladder Cancer By Combination Therapy Comprising The Oncolytic Adenovirus CG0070 And An Immune Checkpoint Inhibitorgranted
- Methods Of Treating Bladder Cancer With An Oncolytic Virusgranted
- Methods Of Treating Solid Or Lymphatic Tumors By Combination Therapyapplication
- Live And In-vivo Tumor Specific Cancer Vaccine System Developed By Co-administration Of Either At Least Two Or All Three Of The Following Components Such As Tumor Cells, An Oncolytic Virus Vector With Transgenic Expression Of Gm-csf And An Immune Checkpoint Modulatorapplication
- Methods Of Treating Solid Or Lymphatic Tumors By Combination Therapyapplication
- Methods Of Treating Bladder Cancer Using An Oncolytic Virusapplication
- Methods Of Treating Non-muscle Invasive Bladder Cancerapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.